"Pheochromocytoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)
| Descriptor ID |
D010673
|
| MeSH Number(s) |
C04.557.465.625.650.700.725 C04.557.580.625.650.700.725
|
| Concept/Terms |
Pheochromocytoma, Extra-Adrenal- Pheochromocytoma, Extra-Adrenal
- Extra-Adrenal Pheochromocytoma
- Extra-Adrenal Pheochromocytomas
- Pheochromocytoma, Extra Adrenal
- Pheochromocytomas, Extra-Adrenal
|
Below are MeSH descriptors whose meaning is more general than "Pheochromocytoma".
Below are MeSH descriptors whose meaning is more specific than "Pheochromocytoma".
This graph shows the total number of publications written about "Pheochromocytoma" by people in this website by year, and whether "Pheochromocytoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 2 | 4 |
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 2 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2022 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pheochromocytoma" by people in Profiles.
-
Clinical Significance of Pheochromocytoma Size on the Timing and Extent of Surgery. J Surg Res. 2024 Jun; 298:88-93.
-
P300/CBP Regulates HIF-1-Dependent Sympathetic Activation and Hypertension by Intermittent Hypoxia. Am J Respir Cell Mol Biol. 2024 Feb; 70(2):110-118.
-
Transcriptome-guided resolution of tumor microenvironment interactions in pheochromocytoma and paraganglioma subtypes. J Endocrinol Invest. 2022 May; 45(5):989-998.
-
Management recommendations for pancreatic manifestations of von Hippel-Lindau disease. Cancer. 2022 02 01; 128(3):435-446.
-
Lysine demethylase KDM6B regulates HIF-1a-mediated systemic and cellular responses to intermittent hypoxia. Physiol Genomics. 2021 09 01; 53(9):385-394.
-
Pheochromocytoma Resection in a Patient With Chronic Thromboembolic Pulmonary Hypertension and Thrombocytopenia. J Cardiothorac Vasc Anesth. 2021 11; 35(11):3423-3433.
-
Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation. J Clin Endocrinol Metab. 2020 04 01; 105(4).
-
Robot-Assisted Laparoscopic Adrenalectomy. J Endourol. 2018 05; 32(S1):S82-S87.
-
Proliferative changes in the adrenal medulla of aged Chinese native pigs. J Vet Med Sci. 2018 Jun 29; 80(6):968-972.
-
In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease. J Clin Endocrinol Metab. 2018 04 01; 103(4):1631-1638.